News
Filter
China’s innovative drugs gain momentum in global expansion efforts
SHANGHAI, March 18 — In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval....
By ALPHA
2025-07-23
+
Virtual mental health care visits: Making them work for youChinese-made new drugs big hit overseasVirtual mental health care visits: Making them work for you
Domestic pharma firms’ enthusiasm for going global driving business abroad With more Chinese-developed innovative drugs entering both US and European markets, China’s pharmaceutical sector is showing escalating prowess in innovation and global market penetration, said industry experts. “This (entering the...
By ALPHA
2025-07-23
+
Accelerating Chinese Innovative Drugs Going Global: International New Drug R&D Regulation Forum Successfully Held
A new round of technological revolution and industrial transformation in global biomedicine is accelerating, with innovative drugs becoming the most crucial strategic development direction in the biopharmaceutical industry. Since 2016, China’s innovative drug R&D has entered the fast track and...
By ALPHA
2025-07-23
+